Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Physical Review Letters|November 5, 2004
Angle resolved photoemission from Nd1.85Ce0.15CuO4 using high energy photons: a fermi surface investigationT Claesson, M Månsson, C Dallera, et al.
The American Journal of Managed Care|May 26, 1999
Factors affecting patient compliance with antihyperlipidemic medications in an HMO populationJ C Sung, M B Nichol, F Venturini, et al.
Physical Review Letters|September 13, 2002
Observation of an unconventional metal-insulator transition in overdoped CuO2 compoundsF Venturini, M Opel, T P Devereaux, et al.
Physical Review Letters|October 26, 2005
Experimental observation and theoretical description of the pure Fano effect in the valence-band photoemission of ferromagnetsJ Minár, H Ebert, C De Nadaï, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 6, 2009
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcomeP L Zinzani, F Venturini, V Stefoni, et al.
Cancer Treatment Reviews|December 7, 2010
Therapeutic implications of resistance to molecular therapies in metastatic colorectal cancerA Sartore-Bianchi, K Bencardino, A Cassingena, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 20, 2026
Telepharmacy-supported multidisciplinary management and clinical outcomes in patients with transthyretin amyloid cardiomyopathy treated with tafamidis: a real-world studyL Cordiano, D Condello, G Chinellato, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 29, 2009
MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis: experience on seven patientsE Derenzini, M P Fina, V Stefoni, et al.
Physical Review Letters|October 10, 2006
Transfer of spectral weight and symmetry across the metal-insulator transition in VO(2)T C Koethe, Z Hu, M W Haverkort, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
READY: REAl-world Data from an Italian compassionate use program of avelumab first-line maintenance for locallY advanced or metastatic urothelial carcinomaL Antonuzzo, M Maruzzo, U De Giorgi, et al.
Pageof 3